(Q24794829)

2

0 references

Chaofeng Liu

3

0 references

Madelaine M Wohlreich

4

0 references

Joel Raskin

A rating scale for depression

5

0 references

language of work or name

English

0 references

publication date

2005

0 references

published in

BMC Psychiatry

0 references

volume

5

0 references

issue

1

0 references

page(s)

1

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Inflammatory markers in major depression and melancholia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Are the newer antidepressant drugs as effective as established physical treatments? Results from an Australasian clinical panel review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Is psychotherapy an effective treatment for melancholia and other severe depressive states?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Melancholic/endogenous depression and response to somatic treatment and placebo

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Gender differences in depression risk and coping factors in a clinical sample.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

The Melancholia Scale and the Newcastle Scales. Item-combinations and inter-observer reliability.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Treatment outcome validation of DSM-III depressive subtypes. Clinical usefulness in outpatients with mild to moderate depression.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Buspirone in the management of major depression: a placebo-controlled comparison.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Does melancholia predict response in major depression?

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Predicting the course of melancholic and nonmelancholic depression. A naturalistic comparison study

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

The endogenous--neurotic distinction as a predictor of response to antidepressant drugs

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Melancholia and axis II comorbidity

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-1

Disordered personality style: higher rates in non-melancholic compared to melancholic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-1

The diagnostic validity of melancholic major depression in a population-based sample of female twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-1

Comorbid personality disorder predicts suicide after major depression: a 10-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-1

Efficacy of SSRIs and Newer Antidepressants in Severe Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-1

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-1

Melancholia: definitions, risk factors, personality, neuroendocrine markers and differential antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-1

Cluster analytic validation of the DSM melancholic depression. The threshold model: integration of quantitative and qualitative distinctions between unipolar depressive subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-1

Relationship between body-mass index and depressive symptoms in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-1

Clinical Effects of the 5-HT1A Partial Agonists in Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-1

Diagnostic Criteria for Melancholia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-1

Duloxetine for the treatment of major depressive disorder.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Sub-typing depression, I. Is psychomotor disturbance necessary and sufficient to the definition of melancholia?

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=546184

Gender Differences in Severity, Symptomatology and Distribution of Melancholia in Major Depression

28 November 2018

1 reference

12 December 2020

Research diagnostic criteria subtypes of depression. Their role as predictors of differential response to psychotherapy and drug treatment

1 reference

12 December 2020

Melancholic subtyping: a qualitative or quantitative distinction?

1 reference

12 December 2020

Which depressions respond to placebo?

1 reference

12 December 2020

Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

Decreased plasma serotonin in melancholic patients: A study with clomipramine

1 reference

12 December 2020

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

Impaired in vivo immune responses in patients with melancholia

1 reference

12 December 2020

Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia

1 reference

12 December 2020

Outpatients with DSM-III-R versus DSM-IV melancholic depression

1 reference

12 December 2020

The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale

1 reference

12 December 2020

Relationship Between Blood Serotonergic Variables, Melancholic Traits, and Response to Antidepressant Treatments

1 reference

12 December 2020

Predicting the Course of Melancholic and Nonmelancholic Depression

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-1

7 January 2021